Article
Cure Leukaemia - Charity Case Study
With enough research and development into treatment, medical science will find an answer.
That's exactly what Cure Leukaemia has been able to discover over the last twenty years, whilst saving thousands of lives in the meantime!
Like all great campaigns, they need constant resources and innovation to create the new medical breakthroughs!
Cure Leukaemia
Cure Leukaemia was established in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley to allow patients with blood cancer in the Birmingham region to access remarkably effective new treatments which were then becoming available. Since then, Cure Leukaemia has been able to expand to a national level, and we are now able to offer potential life-saving treatment to patients across the UK. Thanks to our huge CL Family of dedicated fundraisers, we’ve been able to continue to grow each year and connect more patients to potentially lifesaving treatment.
The Trials Acceleration Programme (TAP).
The Trials Acceleration Programme (TAP):

In January 2020, Cure Leukaemia began a 3-year, £3,000,000 commitment to funding the national Trials Acceleration Programme (TAP). The TAP Network allows patients to be connected with world-class and potentially lifesaving treatment that would otherwise not be available to them through standard care.
The TAP network allows a catchment area of over 20,000,000 patients to be connected with world-class and potentially lifesaving treatments that would otherwise not be available to them through standard care – with over 40,000 people diagnosed with blood cancer every year.
share this
Related Articles
Related Articles

STAY UP TO DATE
GET PATH'S LATEST
Receive bi-weekly updates from the church, and get a heads up on upcoming events.
Contact Us

